Bioaffinity Technologies, Inc.
SEC CIK 1712762 · BIAF · last insider filing 2025-09-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Oppenheimer John J. | Director | filed 2025 - 2025 |
| Rios Roberto | Director | filed 2025 - 2025 |
| Girgenti Steven | Director · Executive Chairman | filed 2022 - 2025 |
| Zannes Maria | Director · President, CEO | filed 2022 - 2025 |
| Knight Peter S | Director | filed 2022 - 2024 |
| Diamond Stuart | Director | filed 2022 - 2024 |
| Anderson Robert A. | Director | filed 2022 - 2024 |
| Rubin Gary D | Director | filed 2022 - 2024 |
| Joyce Roby | Director | filed 2023 - 2024 |
| Platt Jamie | Director | filed 2023 - 2024 |
| Meghji Mohsin Y | Director | filed 2023 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Edwards James Michael | VP and CFO | filed 2022 - 2025 |
| Zannes Timothy P | Secretary, EVP, Gen. Counsel | filed 2022 - 2025 |
| Reveles Xavier Trinidad | Chief Operating Officer | filed 2023 - 2025 |
| Rebel Vivienne I | EVP, Chief Sci. & Med. Officer | filed 2022 - 2024 |
| Dougherty Michael Philip | Chief Financial Officer | filed 2023 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.